Cromolyn sodium and masitinib combination inhibits fibroblast‐myofibroblast transition and exerts additive cell‐protective and antioxidant effects on a bleomycin‐induced in vitro fibrosis model

• Үндсэн зохиолчид: Azize Yasemin Göksu (Зохиогч), Hulya Dirol (Зохиогч), Fatma Gonca Kocanci (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Wiley, 2024-10-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Abstract Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal fibrotic lung disease. While recent studies have suggested the potential efficacy of tyrosine kinase inhibitors in managing IPF, masitinib, a clinically used tyrosine kinase inhibitor, has not yet been investigated for its effic...